Table 3.
Study | Patients | Age | LN (n) | Localization | Tumor/Non-Tumor | Reported Age-Related Morphological Changes |
---|---|---|---|---|---|---|
Hadamitzky | 41 | 17–98 | 41 | nm | non-tumor | Loss of lymphocytes/high endothelial venules, degree of fibrosis and lipomatosis |
Pan | 7 | 81–98 | 161 | head and neck | nm | transparent LN |
Erofeeva | 10 | 75–90 | nm | carinal/lower tracheo-bronchial | non-tumor | Thick edematous capsule, fibrous trabeculae located between the capsule and the node parenchyma, enlarged blood vessels, and a suppression of lymphocytopoietic function |
Erofeeva | nm | 77 +/− 6.78 | 13 | mesenteric | non-tumor | Thickening of the capsule and trabeculae, proliferation of connective tissue around blood vessels and in the lymphoid parenchyma, lipomatosis of both cortical and medulla, decrease in the cell density in all structural components |
Murakami | 42 | 68–95 | 419 | cervical, axillary, thoraxix, abdominal, pelvic, inguinal | non-tumor | Gaps in the cortex, fatty tissue infiltration, hyalinization |
Tsakraklides | 487 | <16–>60 | 2250 | axillary | tumor/non-tumor | Hyaline deposits increase with age |
Denz | 150 | nm | 300 | deep cervical, inguinal, bronchial, mesenteric, axillary | tumor/non-tumor | Differences in LN function and anatomical position, retrogression of lymphoid tissue commences at puberty, lipomatous atrophy depends on nutritional state, collagenous and fibrous change |
Luscieti | nm | 0–90 | 243 | cervical, axillar, cubital, inguinal, popliteal, mesenteric | non-tumor | Differences in anatomical position in size, lympatic tissue, and lipomatous atrophy |
Taniguchi | 27 + 12 | 72–95 | 519 | cervical, axillar, mediastinal, abdominal, pelvic | non-tumor | Differences in hyalinization (mediastinal vs. pelvic type) |
Sato | 27 | 72–95 | 205 | abdominal, pelvic | non-tumor | Region-specific histological heterogeneity with gap formation and thickend trabeculae |
nm = not mentioned.